Paushak — 360° view

Paushak, a company in the Specialty Chemicals industry, reported revenue of ₹89 crore and net profit of ₹14 crore for the September 2026 quarter.

Paushak (NSE: PAUSHAKLTD) closed at ₹557.30 on 20 Nov 2026. Its market capitalisation is ₹1,374 crore and it trades at 29.1 times earnings.

Share price
₹557.30 (20 Nov 2026)
Market cap
₹1,374 Cr (20 Nov 2026)
P/E
29.06 (20 Nov 2026)
Revenue
₹89 Cr (September 2026 quarter)
Net profit
₹14 Cr (September 2026 quarter)
ROCE
8.30% (FY26)
ROE
6.98% (FY26)
Book value
₹210 (FY26)
Dividend yield
0.45% (last 12 months to 20 Nov 2026)
52-week high / low
₹881.95 / ₹342.50 (20 Nov 2026)
Sector
Commodities
Industry
Specialty Chemicals
Symbol
NSE: PAUSHAKLTD

Paushak is India’s largest phosgene based specialty chemicals manufacturer serving pharmaceutical, agrochemical and performance industries. Paushak is part of the Alembic group of companies situated in Gujarat, India.. Alembic Ltd is the oldest pharmaceutical company in India founded in 1907.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.